Results 101 to 110 of about 34,664 (179)

Towards the institutionalization of wastewater surveillance for public health: results from the EU-WISH mapping survey. [PDF]

Eur J Public Health
Baz-Lomba JA, Perälä J, Pitkänen T, Leino T.   +3 more
europepmc   +1 more source

Commentary on "Exploring the Phenotypic Profile of Acute Flaccid Paralysis: Insights from a Third-Level Pediatric Emergency Room". [PDF]

Iran J Child Neurol
Hosseinpour S, Ashrafi MR, Heidari M, Parvaneh N, Tavasoli AR.   +4 more
europepmc   +1 more source

Effectiveness of poliovirus environmental surveillance in Ghana: an indicator-based performance evaluation across seven regions, 2018-2022. [PDF]

BMJ Open
Obodai E, Asante Ntim NA, Duker EO, Gberbi E, Antwi CN, Mensah JY, Odame D, Boakye JD, Bimpong SA, Agbotse GD, Odoom N, Adams PL, Acquah NK, Dickson AE, Odoom C, Achempem KK, Baffoe-Nyarko I, Egbi G, Laryea D, Asiedu-Bekoe F, Odoom JK.   +20 more
europepmc   +1 more source

A Pseudovirus-Based Method for the Simultaneous Quantitation of Neutralization Antibodies Against All Three Poliovirus Serotypes. [PDF]

MedComm (2020)
Liu M, Yu Y, Li Y, Tao Z, Huang L, Wu X, Zhang Y, Zhu S, Sun Q, Ji T, Wang D, Liang Z, Liu S, Cai M, An Y, Li J, Huang W, Liao G, Yi L, Ma L, Zhang L, Wang Y.   +21 more
europepmc   +1 more source

Higher stability of novel live-attenuated oral poliovirus type 2 (nOPV2) despite the emergence of a neurovirulent double recombinant strain in Uganda. [PDF]

Nat Microbiol
Tushabe P, Majumdar M, Carlyle S, Shulman L, Ssekagiri A, Joffret ML, Klapsa D, Cremer J, Arowolo KO, Bujaki E, Bukenya H, EPI Laboratory team, Nanteza MB, Turyahabwe I, Namuwulya P, Birungi M, Eliku JP, Aine F, Tibanagwa M, Nakabazzi L, Gaizi J, Ssebuuma AM, Dhatemwa R, Okia C, Nyachwo M, Nanteza MB, Turyahabwe I, Namuwulya P, Birungi M, Eliku JP, Aine F, Tibanagwa M, Nakabazzi L, Gaizi J, Ssebuuma AM, Dhatemwa R, Okia C, Nyachwo M, Hawes KM, Bakamutumaho B, Duizer E, Bessaud M, Bandyopadhyay AS, Macadam A, Byabamazima CR, Martin J, Bwogi J.   +46 more
europepmc   +1 more source

Virucidal efficacy of a UV-C disinfection system for semi-critical medical devices according to EN 14476. [PDF]

GMS Hyg Infect Control
Rudhart SA, Eichhorn KWG, Rausch M, Maas A, Knof M, Engelhart S, Mutters NT, Hoch S, Strieth S.   +8 more
europepmc   +1 more source

Factors associated with the circulation of vaccine-derived polioviruses in children under five in Kilwa, Haut-Katanga province, Democratic Republic of Congo, 2022-2023. [PDF]

BMC Infect Dis
Iyala JBY, Degbey CC, Elumbu G, Tshinkenke BK, Nadakou N, Kieng GK, Tuni BN, Makala JP.   +7 more
europepmc   +1 more source

Estimating population immunity against serotype-two poliomyelitis from the inactivated polio vaccine in routine immunization across 112 countries: A modelling study. [PDF]

PLoS Med
Gray EJ, Cooper LV, Gonzalez AR, Mach O, Derqui N, Grassly NC, Blake IM.   +6 more
europepmc   +1 more source

Characterization of a Sabin-like type 2/3 recombinant poliovirus with a triple nucleotide deletion in the VP1 region isolated from sewage. [PDF]

Virol J
Lin J, Zhou L, Zhu C, Li J, Zhang W, Zhu S, Wang D, Li X, Zhu H, Yang Q, Ji T, Xiao J, Yang L, Xiao K, Shao K, Zhang Y, Yan D.   +16 more
europepmc   +1 more source

Intramuscular versus intradermal administration of fractional dose inactivated poliovirus vaccine in Mozambique, 2020-2022: an, open-label, non-inferiority, randomised, controlled phase 2 trial. [PDF]

EClinicalMedicine
Omar Viegas E, Fumane E, Pereira K, Amade M, Jani I, Guilche O, Cubai C, Valdez S, Mainou BA, Lopez Cavestany R, Jeyaseelan V, Mach O.   +11 more
europepmc   +1 more source